Robert Lenz
Förmögenhet: 571 820 $ per 2026-05-31
Förmögenhet: 571 820 $ per 2026-05-31
Robert A. Lenz is currently Co-Managing Director at Lenz, Kämper GmbH & Co. KG.
He is also an Independent Director at LB Pharmaceuticals, Inc. starting in 2026 and an Independent Director at NovaBridge Biosciences starting in 2025.
Formerly, Dr. Lenz was Senior Vice President & Head-Global Development at Amgen, Inc. and Head-Research & Development at Neumora Therapeutics, Inc. Dr. Lenz earned a doctorate from the University of Maryland and completed undergraduate studies at Dickinson College.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2025-02-18 | 309 092 ( 0,17 % ) | 571 820 $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| NOVABRIDGE BIOSCIENCES | Direktör/Styrelseledamot | 2025-08-22 |
| LB PHARMACEUTICALS INC | Direktör/Styrelseledamot | 2026-03-06 |
Lenz, Kämper GmbH & Co. KG
Lenz, Kämper GmbH & Co. KG Electrical ProductsProducer Manufacturing Manufactures and supplies bent wire parts | Verkställande Direktör | - |
| Företag | Position | Slut |
|---|---|---|
| NEUMORA THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | - |
| AMGEN INC. | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 7 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Dickinson College
Dickinson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland
University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lenz, Kämper GmbH & Co. KG
Lenz, Kämper GmbH & Co. KG Electrical ProductsProducer Manufacturing Manufactures and supplies bent wire parts | Producer Manufacturing |
LB Pharmaceuticals, Inc.
LB Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression and neuropsychiatric diseases | Health Technology |
I-Mab
I-Mab Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer and autoimmune diseases | Health Technology |
Neumora Therapeutics, Inc.
Neumora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops medicines for brain diseases | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån